Rycarma Therapeutics

Developer of small molecule therapeutics for cardiovascular and skeletal muscle diseases

placeArdsley, New York, United States calendar_todayFounded 2004 language rycarma.com

Innovation

8 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 21 times.

YearFilings
20121
20161
20232
20241
20255
20262

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon